Circumvent logo — company profile

Circumvent

Founded 2017 United States Portland, United States 7 employees Grant Total: $7.93M Biotechnology, Health Care +1

General Information

Company Name Circumvent
Founded Year 2017
Location United States Portland, United States +1
Employees 7
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Grant
Social

Get notified when Circumvent moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Circumvent

Circumvent Pharmaceuticals, founded in 2017 and headquartered in the United States, is dedicated to addressing the unmet needs of neurodegenerative disease patients. The company focuses on heritable forms of neurodegeneration, aiming to facilitate drug discovery and development for both rare and common forms of neurodegenerative diseases. Notably, Circumvent has secured funding from prominent entities such as NIH/NINDS, YC Bio, Heritage Provider Network, and the Longevity Fund. The company's most recent investment, a $495.00K grant, was received on 01 November 2021. Positioned at the intersection of biotechnology, healthcare, and pharmaceutical industries, Circumvent Pharmaceuticals is making significant strides in combating neurodegenerative diseases, garnering support and resources from key players in the healthcare and investment sectors.

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• - 01 Nov 2021
Grant •••••• - 01 Nov 2021
Grant •••••• - 01 Nov 2021
Seed Round •••••• 3
Investor
•••• ••••
09 Dec 2020
Pre Seed Round •••••• 1
Investor
18 Mar 2019

Circumvent Alternatives & Competitors

Circumvent vs
AcuraStem
AcuraStem United States

Patient-Based Therapeutics

Grant
25 employees
AI, Biotechnology
Circumvent vs
AFFiRiS AG
AFFiRiS AG Austria

Novel disease-modifying therapies for neurodegenerative diseases. From brains for brains. From us fo...

Unknown
2 employees
Biotechnology, Pharmaceutical
Circumvent vs

Pioneering advanced therapies for Alzheimer's, Parkinson's, and other neurodegenerative diseases.

Series Unknown
Health Care, Pharmaceutical
Also compare with: Circumvent vs Vanqua Bio Vanqua Bio

FAQ About Circumvent

Circumvent Pharmaceuticals is seeking to address the significant unmet need of neurodegenerative disease patients. Circumvent is targeting heritable forms of neurodegeneration to enable drug discovery and development in both rare and common forms of neurodegenerative disease. Circumvent is funded by...
Circumvent was founded in 2017.
Circumvent is headquartered in Portland, United States.
Circumvent operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
Circumvent has approximately 7 employees.
Circumvent has completed 5 funding rounds, raising a total of $7.93M. The latest funding stage is Grant.
Top alternatives and competitors to Circumvent include AcuraStem, AFFiRiS AG, Satori Pharmaceuticals, Vanqua Bio, Enterin Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Circumvent and AcuraStem are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Circumvent and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy